The mean Hb decrease in patients with a pathological diagnosis of HCC was 5.4% ± 3.3%, while it was 6.9% ± 4.1% in the group with metastases, with no significant difference between the two groups (P = 0.447) (Table 1). Here, GSTM1 is linked to hepatocellular carcinoma.